Document is current
Any future updates will be listed below
-
Authors
Cheng, Yaqi
Chen, Huaxin
Gu, Simin
Li, Weihua
Yu, Huan
Zhang, Jianqiang
Zhang, Huini
Lin, Jiayi
Zhu, Haocheng
Liu, Youyu
Li, Wenqiong
Fu, Ting
Zeng, Haoyu
Wang, Tao
Ling, Shiqi
-
Funding
Funding for this research was provided by:
Guangzhou Huangpu International Science and Technology Collaboration Project (2021GH08)
Guangzhou Science and Technology Planning Project (2024A03J0278)
Basic and Applied Basic Research Foundation of Guangdong Province (2023A1515110232)
Open Research Funds of the State Key Laboratory of Ophthalmology (2023)
- License Information
-
More Information
Article History
Received: 25 January 2025
Accepted: 3 July 2025
First Online: 15 July 2025
Declarations
:
: All animal experiments for this study were in accordance with the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines 2.0. All procedures were approved by the Ethics Committee of Zhongshan Ophthalmic Center Animal Care and Ethics Committee. The research project titled “Study on the therapeutic effect and mechanism of stem cells and NU7441 in ocular surface and fundus diseases” was approved on November 01, 2023 (ethical approval number: O2023048). Human UC-MSCs related procedures were approved by the Ethics Committee of Third Affiliated Hospital, Sun Yat-sen University. The research project titled “Research on the Role and Mechanism of Mesenchymal Stem Cell Therapy in Treating Corneal Transplant Rejection and Dry Eye Syndrome” was approved on February 07, 2024 (ethical approval number: A2024-78-01). The patients provided written informed consent for the use of samples.
: Not applicable.
: The authors declare no competing interests.
: The authors declare that they have not used Artificial Intelligence in this study.
